Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Meribel Pharma Höganäs AB
AB
Active
Org 5566662606
Sporthallsvägen 6, 263 35
Höganäs
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2004
50-99 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Meribel Pharma Höganäs AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
54M
108M
161M
215M
86M
2020
124M
2021
163M
2022
187M
2023
174M
2024
EBITDA
SEK millions
0M
-1M
-1M
-2M
-2M
-18M
2020
-18M
2021
-11M
2022
-2M
2023
-29M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
85 744
123 758
162 943
187 265
173 889
Staff expenses
—
—
—
—
—
EBITDA
−17 792
−17 821
−11 418
−2 060
−29 234
Depreciation & amort.
−4 805
−6 596
−6 458
−6 814
−6 575
EBIT
−22 597
−24 417
−17 876
−8 874
−35 809
Net financials
−278
−4 185
−5 254
−7 238
−4 378
Profit before tax
−1 624
−71
−23 130
15 112
−2 175
Tax
−0
−0
3 803
−3 803
−0
Net profit
−1 624
−71
−19 327
11 309
−2 175
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
132 299
134 581
120 121
178 291
184 821
Equity
23 458
27 258
7 931
19 240
137 065
Long-term debt
70
0
0
0
0
Short-term debt
108 771
107 323
112 190
159 051
47 756
Total debt
108 841
107 323
112 190
159 051
47 756
Financial ratios
5-year trend
EBITDA margin
-16.8%
This company
15.8%
Market median
-206% vs market
2020
2024
Equity ratio
74.2%
This company
38.2%
Market median
+94% vs market
2020
2024
Return on equity
-1.6%
This company
18.4%
Market median
-109% vs market
2020
2024
Net profit margin
-1.3%
This company
8.1%
Market median
-116% vs market
2020
2024
Asset turnover
0.94×
This company
1.12×
Market median
+16% vs market
2020
2024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Meribel Pharma Höganäs AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
